Display options
Share it on

Arch Plast Surg. 2015 Mar;42(2):194-200. doi: 10.5999/aps.2015.42.2.194. Epub 2015 Mar 16.

Early Surgical Site Infection Following Tissue Expander Breast Reconstruction with or without Acellular Dermal Matrix: National Benchmarking Using National Surgical Quality Improvement Program.

Archives of plastic surgery

Sebastian Winocour, Jorys Martinez-Jorge, Elizabeth Habermann, Kristine Thomsen, Valerie Lemaine

Affiliations

  1. Division of Plastic Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA.
  2. Department of Health Sciences Research, Rochester, NM, USA.

PMID: 25798391 PMCID: PMC4366701 DOI: 10.5999/aps.2015.42.2.194

Abstract

BACKGROUND: Surgical site infections (SSIs) result in significant patient morbidity following immediate tissue expander breast reconstruction (ITEBR). This study determined a single institution's 30-day SSI rate and benchmarked it against that among national institutions participating in the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP).

METHODS: Women who underwent ITEBR with/without acellular dermal matrix (ADM) were identified using the ACS-NSQIP database between 2005 and 2011. Patient characteristics associated with the 30-day SSI rate were determined, and differences in rates between our institution and the national database were assessed.

RESULTS: 12,163 patients underwent ITEBR, including 263 at our institution. SSIs occurred in 416 (3.4%) patients nationwide excluding our institution, with lower rates observed at our institution (1.9%). Nationwide, SSIs were significantly more common in ITEBR patients with ADM (4.5%) compared to non-ADM patients (3.2%, P=0.005), and this trend was observed at our institution (2.1% vs. 1.6%, P=1.00). A multivariable analysis of all institutions identified age ≥50 years (odds ratio [OR], 1.4; confidence interval [CI], 1.1-1.7), body mass index ≥30 kg/m(2) vs. <25 kg/m(2) (OR, 3.4; CI, 2.6-4.5), and operative time >4.25 hours (OR, 1.9; CI, 1.5-2.4) as risk factors for SSIs. Our institutional SSI rate was lower than the nationwide rate (OR, 0.4; CI, 0.2-1.1), although this difference was not statistically significant (P=0.07).

CONCLUSIONS: The 30-day SSI rate at our institution in patients who underwent ITEBR was lower than the nation. SSIs occurred more frequently in procedures involving ADM both nationally and at our institution.

Keywords: Acellular dermis; Benchmarking; Breast implantation; Surgical wound infection

References

  1. Ann Plast Surg. 2013 Jan;70(1):103-10 - PubMed
  2. Plast Reconstr Surg. 2013 Jan;131(1):15-23 - PubMed
  3. J Am Coll Surg. 2010 Jan;210(1):60-5.e1-2 - PubMed
  4. Dis Colon Rectum. 2013 Jan;56(1):64-71 - PubMed
  5. Aesthetic Plast Surg. 2008 May;32(3):418-25 - PubMed
  6. Plast Reconstr Surg. 2013 Mar;131(3):320e-6e - PubMed
  7. J Plast Reconstr Aesthet Surg. 2013 Nov;66(11):1504-12 - PubMed
  8. J Infect Dis. 2005 Apr 1;191(7):1056-62 - PubMed
  9. Plast Reconstr Surg. 2013 Oct;132(4):725-36 - PubMed
  10. J Am Coll Surg. 2013 Oct;217(4):656-64 - PubMed
  11. Plast Reconstr Surg. 2013 Feb;131(2):195-203 - PubMed
  12. Plast Reconstr Surg. 2011 Dec;128(6):1170-8 - PubMed
  13. Plast Reconstr Surg. 2012 Jan;129(1):28-41 - PubMed
  14. Plast Reconstr Surg. 2008 Jun;121(6):1886-92 - PubMed
  15. Plast Reconstr Surg. 2007 Aug;120(2):373-81 - PubMed
  16. Br J Plast Surg. 1999 Jan;52(1):33-6 - PubMed
  17. J Am Coll Surg. 2010 Jan;210(1):6-16 - PubMed
  18. Plast Reconstr Surg. 2011 Dec;128(6):1182-7 - PubMed
  19. Plast Reconstr Surg. 2010 Feb;125(2):429-36 - PubMed
  20. Ann Plast Surg. 2013 Nov;71(5):464-70 - PubMed
  21. Plast Reconstr Surg. 2009 Dec;124(6):1790-6 - PubMed
  22. Lancet Infect Dis. 2005 Feb;5(2):94-106 - PubMed

Publication Types